Kinderhook Industries acquires Enhabit Home Health & Hospice

Kinderhook Industries has agreed to acquire Enhabit Inc. in a $1.1 billion all-cash transaction. The acquisition, announced on February 23, 2026, will take the publicly traded Enhabit private, a move that aligns with the trend of private equity firms targeting the healthcare sector. This deal underscores the rising appeal of businesses catering to an aging population with a preference for home-based medical and palliative care.

Enhabit Inc., which operates across 34 states, is known for providing skilled nursing, rehabilitation, and palliative care services. The acquisition aims to leverage Kinderhook's financial resources and strategic expertise to augment Enhabit's service delivery and geographic reach. Completion is scheduled for the second quarter of 2026, subject to regulatory approval and standard closing conditions. Upon closing, Enhabit's shares will cease trading, effectively delisting the company from the New York Stock Exchange.

Barb Jacobsmeyer, CEO of Enhabit, remarked that this transaction benefits stakeholders by enabling long-term investment in the company’s workforce and clinical innovations. She pointed out that Kinderhook's ownership will unshackle Enhabit from the short-term pressures of the public markets, pivoting the company’s focus towards sustainable growth and improved patient outcomes. This sentiment is echoed by Enhabit’s board chairman, Jeffrey Bolton, who confirmed that the board determined the deal delivers maximum stockholder value following a thorough evaluation.

As part of the acquisition terms, Enhabit shareholders will receive $13.80 per share in cash, marking a premium of 24.4% over the company's last closing stock price before the deal's announcement. This pricing also represents a 33.8% premium over Enhabit’s 60-day volume-weighted average price, providing an attractive exit for investors and signaling confidence in the company’s long-term potential amid evolving healthcare demands.

Kinderhook Industries, with over $10 billion in committed capital, has a history of focusing on companies with strong market positions. Its healthcare portfolio already includes entities such as Better Health Group and AbsoluteCare, showcasing a consistent strategy to invest in value-based healthcare services. This acquisition of Enhabit fits within Kinderhook's broader strategy of enhancing its portfolio's competitive positioning in the healthcare landscape.

Future considerations include navigating regulatory approvals and integrating Enhabit into Kinderhook’s healthcare portfolio, ensuring a seamless transition and operational continuity. These factors will be pivotal in determining the success of the acquisition and the extent to which Enhabit can capitalize on Kinderhook's resources to further its expansion and impact in the home health care sector.